Heart Test Laboratories Stock (NASDAQ:HSCS)
Previous Close
$3.15
52W Range
$2.94 - $85.20
50D Avg
$3.83
200D Avg
$10.10
Market Cap
$2.52M
Avg Vol (3M)
$59.63K
Beta
3.16
Div Yield
-
HSCS Company Profile
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
HSCS Performance
Peer Comparison
Ticker | Company |
---|---|
NURO | NeuroMetrix, Inc. |
TLIS | Talis Biomedical Corporation |
INVO | INVO Bioscience, Inc. |
TIVC | Tivic Health Systems, Inc. |
NUWE | Nuwellis, Inc. |
BVS | Bioventus Inc. |
IINN | Inspira Technologies Oxy B.H.N. Ltd. |
OPGN | OpGen, Inc. |
RSLS | ReShape Lifesciences Inc. |
BBLG | Bone Biologics Corporation |
BJDX | Bluejay Diagnostics, Inc. |
MOTS | Motus GI Holdings, Inc. |
TNON | Tenon Medical, Inc. |